Minoru Maruyama

Title: Minoru Maruyama: Innovator in Mental Health Solutions

Introduction

Minoru Maruyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of mental health through his innovative research and patenting activities. His work focuses on developing compounds that can aid in the prevention and treatment of various mental disorders.

Latest Patents

Minoru Maruyama holds a patent related to screening methods using GPR52. The patent discloses compounds or their salts that promote or inhibit the activities of a protein with an amino acid sequence represented by SEQ ID NO: 1. Additionally, it includes compounds that affect the gene for the protein, antisense polynucleotides that are complementary to the base sequence of a polynucleotide encoding the protein, and antibodies to the protein. These innovations can be utilized as agents for the prevention and treatment of mental disorders and prolactin-related disorders.

Career Highlights

Minoru Maruyama is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has allowed him to focus on groundbreaking research that addresses critical health issues. With 1 patent to his name, he continues to contribute to the advancement of medical science.

Collaborations

Throughout his career, Minoru has collaborated with notable colleagues, including Yasuaki Itoh and Hidetoshi Komatsu. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Minoru Maruyama's contributions to the field of mental health through his innovative patents and collaborations highlight his commitment to improving patient care. His work at Takeda Pharmaceutical Company Limited exemplifies the impact of dedicated research in addressing complex health challenges.